Conference Coverage
-
Conference Coverage
Investigational gene therapy for medically refractory Parkinson’s shows promise
ATLANTA – A randomized, double-blind, placebo surgery–controlled trial of VY-AADC01 is currently recruiting subjects.
-
Conference Coverage
Alemtuzumab switch linked to good MS outcomes
-
Conference Coverage
Ganglion stimulation boosts cerebral blood flow, improves stroke outcomes
-
Conference Coverage
Demyelinating diseases, especially MS, disrupt normal brain development in children
-
Conference Coverage
Anti-MOG antibodies associated with non-MS, monophasic demyelinating disease in young children
BERLIN – Age and anti-MOG antibody status may help to predict a non-MS diagnosis.
-
Conference Coverage
MS disease activity returns in one-third after fingolimod withdrawal
BERLIN – Risk factors for higher disease activity include younger age at diagnosis, shorter disease duration, and stopping more than 2 months...
-
Conference Coverage
New HHS physical activity guidelines break fresh ground
CHICAGO – “Everyone can dramatically improve their health just by moving – anytime, anywhere, and by any means that gets you active.” – Adm. Brett...
-
Conference Coverage
Expert highlights rare causes of stroke to keep in mind
ATLANTA – The list of differential diagnoses can be long.
-
Conference Coverage
Fatigue in MS: Common, often profound, tough to treat
BERLIN – Cognitive behavioral therapy carries the best evidence to treat MS-related fatigue.
-
Conference Coverage
Teenagers with epilepsy may benefit from depression screening
NEW ORLEANS – As much as 8% of patients with pediatric epilepsy may have moderately severe depressive symptoms, and...
-
Conference Coverage
Enzyme-inducing AEDs may raise vitamin D dose requirements
NEW ORLEANS – Patients taking enzyme-inducing antiepileptic drugs required 1,587 units/day of vitamin D to meet the goal – a 409-unit increase in...
-
Conference Coverage
SUDEP risk may change over time
NEW ORLEANS – Risk of SUDEP may decrease among patients initially considered to be at high risk, but remain stable...
-
Conference Coverage
Patients with PNES have increased mortality
NEW ORLEANS – Mortality is similar between patients with PNES and those with drug-resistant epilepsy.
-
Conference Coverage
Patients with epilepsy may develop tolerance to CBD-enriched oil
NEW ORLEANS – About a quarter of patients with treatment-resistant epilepsy develop tolerance to cannabis oil extract.
-
Conference Coverage
Infertility appears to be increased among women with epilepsy
NEW ORLEANS – An analysis finds an infertility rate of 9.2% among women with epilepsy, compared with 6.0% in the...
-
Conference Coverage
New and established AEDs have similar tolerability
NEW ORLEANS – The development of antiepileptic drugs with new mechanisms of action has not improved the tolerability...
-
Conference Coverage
Breastfeeding with MS: Good for mom, too
-
Conference Coverage
Nicotine patch may be an effective precision therapy for select epilepsies
NEW ORLEANS – In select epilepsy patients with gene variants in subunits of the neuronal nicotinic acetylcholine receptor, nicotine may be an...
-
Conference Coverage
Study elicits patients’ most disturbing epilepsy symptoms
NEW ORLEANS – The most prominent symptoms and functional impacts of epilepsy may differ in the early, middle, and late stages of the disease.
Latest News
-
From the Journals
AAP advises moderate physical, cognitive activity after sports concussion
A clinical report from the American Academy of Pediatrics counsels children to return to reduced activities post concussion versus total rest.
-
From the Journals
AEDs strongly linked to rare serious skin reactions
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
-
From the Journals
Dementia linked to increased mortality risk in adults with Down syndrome
Dementia was associated with mortality in 70% of older adults with Down syndrome.
-
Latest News
FDA warns stopping fingolimod linked to severe MS worsening
The FDA has identified 35 cases of severely increased disability accompanied by new MRI lesions that occurred 2-24 weeks after patients stopped...
-
From the Journals
Three commonly used quick cognitive assessments often yield flawed results
Using all three tests together for dementia screening yields more accurate results than any single test.
-
From the Journals
Single-item scale effective for assessing sleep quality
The single-item sleep quality scale (SQS) produced favorable results comparable to more complex assessment tools.
-
From the Journals
Comorbid TBI & PTSD raise the risk for sleep disturbances, pain
-
From the Journals
Motor neuron disease spasticity improved with cannabis-based oral spray, antispasticity drugs
Proof-of-concept trial shows encouraging findings that must be confirmed in larger and longer trials.
-
Latest News
How does CBD compare and interact with other AEDs?
The drug’s most important clinical interaction is with clobazam.
Literature Review
-
Literature Review
Increased risk of atrial fibrillation with migraine aura
Individuals who experience migraine with aura have a higher risk of atrial fibrillation than those without aura or without migraine.
FDA/CDC
-
FDA/CDC
Stroke, arterial dissection events reported with Lemtrada, FDA says
Rare but serious events described in multiple sclerosis patients given alemtuzumab (Lemtrada) prompts new warning.